Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MDCO

Medicines (MDCO) Stock Price, News & Analysis

Medicines logo

About Medicines Stock (NASDAQ:MDCO)

Advanced Chart

Key Stats

Today's Range
$84.90
$84.90
50-Day Range
$84.90
$84.90
52-Week Range
$17.81
$84.98
Volume
N/A
Average Volume
9.55 million shs
Market Capitalization
$6.77 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MDCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicines and its competitors with MarketBeat's FREE daily newsletter.

MDCO Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
See More Headlines

MDCO Stock Analysis - Frequently Asked Questions

The Medicines Company (NASDAQ:MDCO) issued its quarterly earnings results on Wednesday, October, 30th. The company reported ($0.92) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.80) by $0.12.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medicines investors own include Bristol Myers Squibb (BMY), NVIDIA (NVDA), Gilead Sciences (GILD), Micron Technology (MU), AbbVie (ABBV), Alibaba Group (BABA) and Salesforce (CRM).

Company Calendar

Last Earnings
10/30/2019
Today
7/15/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:MDCO
CIK
1113481
Fax
N/A
Employees
62
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.91)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$123.16 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-25.70%

Debt

Debt-to-Equity Ratio
21.45
Current Ratio
0.77
Quick Ratio
0.77

Sales & Book Value

Annual Sales
$6.14 million
Price / Sales
1,102.36
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.30) per share
Price / Book
-283.00

Miscellaneous

Outstanding Shares
79,723,000
Free Float
N/A
Market Cap
$6.77 billion
Optionable
Optionable
Beta
1.10
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:MDCO) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners